Abstract
Patients with end-stage liver disease often undergo surgery for indications other than liver transplantation. These patients have an increased risk of morbidity and mortality that is related to their underlying liver disease. Assessments of surgical risk provide a basis for discussion of risks and benefits, treatment decision making, and for optimal management of patients for whom surgery is planned. The most useful indicators of surgical risk are indices that predict advanced disease, such as the Child–Turcotte–Pugh score, or those that predict prognosis, such as the Model for End-stage Liver Disease score. Careful preoperative risk assessment, patient selection, and management of various manifestations of advanced disease might decrease morbidity and mortality from nontransplant surgery in patients with liver disease.
Key Points
-
Elective surgery should be avoided in patients with acute liver diseases such as acute viral hepatitis or alcoholic hepatitis, if there is evidence of ongoing hepatic injury
-
For patients with chronic liver diseases, determine the severity of underlying disease and assess whether or not cirrhosis might be present before deciding whether to proceed with surgery
-
The Model for End-Stage Liver Disease and Child–Turcotte–Pugh scores can be used to stratify the risks of surgery for patients with chronic liver disease
-
Optimal preoperative management of the manifestations of advanced liver disease can reduce the risk of postoperative morbidity and mortality
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Garrison RN et al. (1984) Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 199: 648–655
Schemel WH (1976) Unexpected hepatic dysfunction found by multiple laboratory screening. Anesth Analg 55: 810–812
Hay JE et al. (1989) The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 9: 193–197
Hultcrantz R et al. (1986) Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 21: 109–113
Delco F (2005) Dose adjustment in patients with liver disease. Drug Saf 28: 529–545
McIntyre N et al. (1996) Cirrhosis, portal hypertension and ascites. In Oxford Textbook of Medicine, edn 3 (eds Weatherall DJ et al.) New York: Oxford University Press
Tegeder I et al. (1999) Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 37: 17–40
Pentikainen PJ et al. (1989) Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 29: 272–277
Ghabrial H et al. (1986) The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol 30: 93–97
Ochs HR et al. (1983) Repeated diazepam dosing in cirrhotic patients: cumulation and sedation. Clin Pharmacol Ther 33: 471–476
Gelman S (1984) Liver circulation and function during isoflurane and halothane anesthesia. Anesthesiology 61: 726–730
Kenna JG (1997) Immunoallergic drug-induced hepatitis: lessons from halothane. J Hepatol 26: 5–12
Groszmann RJ (1994) Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20: 1359–1363
Moller S and Henriksen JH (2002) Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 87: 9–15
Gelman SI (1976) Disturbances in hepatic blood flow during anesthesia and surgery. Arch Surg 111: 881–883
Patel T (1999) Surgery in the patient with liver disease. Mayo Clin Proc 74: 593–599
Friedman LS and Maddrey WC (1987) Surgery in the patient with liver disease. Med Clin North Am 71: 453–476
Dixon JM et al. (1983) Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24: 845–852
Blamey SL et al. (1983) Prediction of risk in biliary surgery. Br J Surg 70: 535–538
Lai EC et al. (1992) Surgery for malignant obstructive jaundice: analysis of mortality. Surgery 112: 891–896
Harville DD and Summerskill WH (1963) Surgery in acute hepatitis. Causes and effects. JAMA 184: 257–261
Powell-Jackson P et al. (1982) Adverse effects of exploratory laparotomy in patients with unsuspected liver disease. Br J Surg 69: 449–451
Greenwood SM et al. (1972) The increased mortality rate of open liver biopsy in alcoholic hepatitis. Surg Gynecol Obstet 134: 600–604
Runyon BA (1986) Surgical procedures are well tolerated by patients with asymptomatic chronic hepatitis. J Clin Gastroenterol 8: 542–544
Hargrove MD Jr (1970) Chronic active hepatitis: possible adverse effect of exploratory laparotomy. Surgery 68: 771–773
Higashi H et al. (1994) Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma. Br J Surg 81: 1342–1345
Behrns KE et al. (1998) Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 2: 292–298
Child CG and Turcotte JG (1964) Surgery and portal hypertension. Major Probl Clin Surg 1: 1–85
Pugh RN et al. (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646–649
Ziser A et al. (1999) Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90: 42–53
del Olmo JA et al. (2003) Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg 27: 647–652
Mansour A et al. (1977) Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122: 730–735
Gines P et al. (1987) Compensated cirrhosis: natural history and prognostic factors. Hepatology 7: 122–128
Malinchoc M et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864–871
Wiesner RH et al. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91–96
Kamath PS et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–470
Chalasani N et al. (2002) Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 35: 1282–1284
Sheth M et al. (2002) Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2: 2
Perkins L et al. (2004) Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2: 1123–1128
Suman A et al. (2004) Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child–Pugh and MELD scores. Clin Gastroenterol Hepatol 2: 719–723
Farnsworth N et al. (2004) Child–Turcotte–Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 188: 580–583
Befeler AS et al. (2005) The safety of intra-abdominal surgery in patients with cirrhosis: Model for End-Stage Liver Disease score is superior to Child–Turcotte–Pugh classification in predicting outcome. Arch Surg 140: 650–654
Northup PG et al. (2005) Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 242: 244–251
Kim YK et al. (1997) Prediction of postoperative decompensated liver function by technetium-99m galactosyl-human serum albumin liver scintigraphy in patients with hepatocellular carcinoma complicating chronic liver disease. Br J Surg 84: 793–796
Ravaioli M et al. (2003) Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis. Hepatogastroenterology 50: 1552–1555
Gill RA et al. (1983) Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg 198: 701–704
Wahlstrom K et al. (2000) Trauma in cirrhotics: survival and hospital sequelae in patients requiring abdominal exploration. Am Surg 66: 1071–1076
Christmas AB et al. (2005) Cirrhosis and trauma: a deadly duo. Am Surg 71: 996–1000
McSherry CK et al. (1980) The incidence and causes of death following surgery for nonmalignant biliary tract disease. Ann Surg 191: 271–275
Metcalf AT et al. (1987) The surgical risk of colectomy in patients with cirrhosis. Dis Colon Rectum 30: 529–531
Bloch RS et al. (1985) Cholecystectomy in patients with cirrhosis. A surgical challenge. Arch Surg 120: 669–672
Sleeman D et al. (1998) Laparoscopic cholecystectomy in cirrhotic patients. J Am Coll Surg 187: 400–403
Azoulay D et al. (2001) Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 193: 46–51
Gil A et al. (2004) The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol 30: 46–52
Klemperer JD et al. (1998) Cardiac operations in patients with cirrhosis. Ann Thorac Surg 65: 85–87
Hayashida N et al. (2004) Clinical outcome after cardiac operations in patients with cirrhosis. Ann Thorac Surg 77: 500–505
Capussotti L et al. (1998) Operative risks of major hepatic resections. Hepatogastroenterology 45: 184–190
Grazi GL et al. (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234: 71–78
Bruix J et al. (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111: 1018–1022
Bruix J and Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208–1236
Schroeder RA et al. (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243: 373–379
French CJ et al. (2003) Cryoprecipitate for the correction of coagulopathy associated with liver disease. Anaesth Intensive Care 31: 357–361
Bernstein DE et al. (1997) Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 113: 1930–1937
Jeffers L et al. (2002) Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 123: 118–126
Levy JH et al. (2006) Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion 46: 919–933
Shao YF et al. (2006) Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg 191: 245–249
Burroughs AK et al. (1985) Desmopressin and bleeding time in patients with cirrhosis. Br Med J (Clin Res Ed) 291: 1377–1381
Riou JP et al. (1992) Factors influencing wound dehiscence. Am J Surg 163: 324–330
Runyon BA (2004) Management of adult patients with ascites due to cirrhosis. Hepatology 39: 841–856
Moreau R et al. (2007) Diagnosis and treatment of acute renal failure in patients with cirrhosis. Best Pract Res Clin Gastroenterol 21: 111–123
Blei AT et al. (2001) Hepatic encephalopathy. Am J Gastroenterol 96: 1968–1976
Als-Nielsen B et al. (2004) Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328: 1046
Mas A et al. (2003) Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J Hepatol 38: 51–58
Reding P et al. (1984) Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 2: 493–495
Bresci G et al. (1993) Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med 2: 414–416
DiCecco SR et al. (1989) Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc 64: 95–102
Schenk P et al. (2003) Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125: 1042–1052
Mazzeo AT et al. (2004) Hepatopulmonary syndrome: a concern for the anesthetist? Pre-operative evaluation of hypoxemic patients with liver disease. Acta Anaesthesiol Scand 48: 178–186
Deibert P et al. (2006) Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry. BMC Gastroenterol 6: 15
Hoeper MM et al. (2004) Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363: 1461–1468
Krowka MJ (2005) Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med 26: 587–597
Krowka MJ et al. (1999) Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 30: 641–648
Hatfield AR et al. (1982) Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet 2: 896–899
McPherson GA et al. (1984) Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg 71: 371–375
Pitt HA et al. (1985) Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 201: 545–553
Lai EC et al. (1994) Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 81: 1195–1198
Lai EC et al. (1992) Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 326: 1582–1586
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hanje, A., Patel, T. Preoperative evaluation of patients with liver disease. Nat Rev Gastroenterol Hepatol 4, 266–276 (2007). https://doi.org/10.1038/ncpgasthep0794
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0794
This article is cited by
-
Evolution of risk prediction models for post-operative mortality in patients with cirrhosis
Hepatology International (2023)
-
Operationsrisiko bei chronischen Lebererkrankungen
Journal für Gastroenterologische und Hepatologische Erkrankungen (2019)